Hints and tips:
Showing results for Vifor Fresenius Medical Care Renal Pharma France S.A.S.
Related Special Reports
...For some pharma groups, notably Sanofi of France, the pandemic was a time of embarrassing and very public underperformance....
...Doctors experimented on vulnerable haemophiliacs in their care without their knowledge or consent; pharma companies offloaded blood products that they knew carried deadly viruses on to countries where low...
...The initial portfolio is heavy with drug and biotech companies, such as Japan’s Astellas Pharma, Germany’s Fresenius Medical Care and Biogen of the US....
...The boom in debt issuance by corporate America has been good to S&P Global, the largest credit rating agency. Its shares have jumped a fifth in 2020, far outpacing its namesake S&P 500 index....
...S&N “should see a recovery in organic sales growth, led by new management” while Spire “could benefit from an increase in NHS outsourcing,” said Morgan Stanley....
...Pharma cut to “neutral” at JPMorgan Cazenove....
...• Fundatia Orange Date founded: 2009 Country: Moldova The Moldova subsidiary of telecoms giant Orange S.A. has a separate social foundation, offering initiatives like Rural Digital Inclusion to increase...
...More broadly, Mr Schneider expects to boost the “medical profile” of Nestlé products, expanding its skin care and nascent “health science” division, which has pushed the Swiss company closer towards becoming...
...(Vifor Fresenius Medical Care has the deal for marketing rights outside the US.)...
...“There’s a lot of interest from both consumer goods companies and big pharma in bioprinting....
...Yet, as the 9 per cent slump in shares of Fresenius Medical Care on Tuesday showed, they remain vulnerable to events....
...Fresenius Medical Care, the dialysis provider, rose 3.2 per cent to €41.37, while Sonova, the hearing aid manufacturer, gained 2.8 per cent to SFr128. The FTSE Eurofirst 300 held steady at 1,065.16....
...Fresenius Medical Care , the German provider of dialysis treatment, added 1.1 per cent to €37.30 after Barclays lifted its price target to €41 from €37....
...Fresenius Medical Care, the German dialysis specialist, fell 4.7 per cent to €33.54 on rumours of a share placement....
...Fresenius, the German healthcare group. rose 3.8 per cent to €55.86 after a press report that it was in talks to buy Italian group Sorin’s renal care business. Sorin shares fell 1.9 per cent to €1.06....
...Dialysis specialist Fresenius Medical Care rose 1 per cent to €96.43 after it raised its full-year forecasts following a 42 per cent rise in second-quarter earnings....
...Germany’s Fresenius Medical Care was up 2.6 per cent after the company announced it had entered a a new sourcing and supply treaty with Amgen in the US....
...Fresenius Medical Care, the German dialysis group, fell 3.7 per cent to €127.10....
...Fresenius Medical Care rose 1.4 per cent to €89.94 after Merrill Lynch raised the price target on the German healthcare group from €85 to €96 and reiterated a “buy” rating....
...Fresenius Medical Care found its shares topping and tailing the FTSE Eurofirst 300 at one point on Wednesday....
International Edition